ReShape Lifesciences Inc. (RSLS)
USD 0.38
(-15.62%)
USD 0.38
(-15.62%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -14.63 Million USD | 45.94% |
| 2022 | -27.07 Million USD | 2.42% |
| 2021 | -27.74 Million USD | -122.76% |
| 2020 | -12.45 Million USD | 21.59% |
| 2019 | -15.88 Million USD | 58.78% |
| 2018 | -38.54 Million USD | -22.73% |
| 2017 | -31.4 Million USD | -37.78% |
| 2016 | -22.79 Million USD | 18.2% |
| 2015 | -27.86 Million USD | -8.89% |
| 2014 | -25.59 Million USD | -3.47% |
| 2013 | -24.73 Million USD | -9.69% |
| 2012 | -22.54 Million USD | 10.72% |
| 2011 | -25.25 Million USD | -56.13% |
| 2010 | -16.17 Million USD | 33.19% |
| 2009 | -24.21 Million USD | 33.25% |
| 2008 | -36.27 Million USD | -29.42% |
| 2007 | -28.02 Million USD | -54.65% |
| 2006 | -18.12 Million USD | -62.49% |
| 2005 | -11.15 Million USD | -223.37% |
| 2004 | -3.44 Million USD | -81.42% |
| 2003 | -1.9 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -2.21 Million USD | -16.62% |
| 2024 Q2 | -2.05 Million USD | 7.06% |
| 2023 Q3 | -3.1 Million USD | 21.96% |
| 2023 Q2 | -3.97 Million USD | 29.39% |
| 2023 Q1 | -5.63 Million USD | -19.66% |
| 2023 FY | -14.63 Million USD | 45.94% |
| 2023 Q4 | -1.89 Million USD | 38.93% |
| 2022 Q1 | -8.4 Million USD | 76.38% |
| 2022 Q2 | -9.24 Million USD | -10.05% |
| 2022 FY | -27.07 Million USD | 2.42% |
| 2022 Q4 | -4.7 Million USD | 61.74% |
| 2022 Q3 | -12.3 Million USD | -33.07% |
| 2021 Q2 | -3.7 Million USD | -64.02% |
| 2021 Q1 | -2.25 Million USD | 29.6% |
| 2021 Q3 | -14.98 Million USD | -304.75% |
| 2021 Q4 | -35.55 Million USD | -137.3% |
| 2021 FY | -27.74 Million USD | -122.76% |
| 2020 Q1 | -4.08 Million USD | -31.05% |
| 2020 FY | -12.45 Million USD | 21.59% |
| 2020 Q3 | -2.17 Million USD | 27.55% |
| 2020 Q4 | -3.2 Million USD | -47.61% |
| 2020 Q2 | -2.99 Million USD | 26.54% |
| 2019 Q3 | -5.61 Million USD | 51.08% |
| 2019 Q2 | -11.48 Million USD | -170.44% |
| 2019 FY | -15.88 Million USD | 58.78% |
| 2019 Q4 | -3.11 Million USD | 44.57% |
| 2019 Q1 | -4.24 Million USD | -123.68% |
| 2018 Q3 | -7.54 Million USD | 17.38% |
| 2018 FY | -38.54 Million USD | -22.73% |
| 2018 Q1 | -12.61 Million USD | -5.72% |
| 2018 Q2 | -9.13 Million USD | 27.61% |
| 2018 Q4 | 17.92 Million USD | 337.65% |
| 2017 Q1 | -7.04 Million USD | -70.5% |
| 2017 Q3 | -5.55 Million USD | 19.12% |
| 2017 Q2 | -6.87 Million USD | 2.39% |
| 2017 Q4 | -11.93 Million USD | -114.6% |
| 2017 FY | -31.4 Million USD | -37.78% |
| 2016 Q4 | -4.13 Million USD | 7.48% |
| 2016 FY | -22.79 Million USD | 18.2% |
| 2016 Q2 | -6.65 Million USD | 11.71% |
| 2016 Q1 | -7.54 Million USD | 0.14% |
| 2016 Q3 | -4.46 Million USD | 32.94% |
| 2015 Q1 | -6.96 Million USD | -14.41% |
| 2015 Q4 | -7.55 Million USD | -25.65% |
| 2015 Q3 | -6.01 Million USD | 18.12% |
| 2015 Q2 | -7.34 Million USD | -5.41% |
| 2015 FY | -27.86 Million USD | -8.89% |
| 2014 Q1 | -6.55 Million USD | -2.89% |
| 2014 Q2 | -7.35 Million USD | -12.14% |
| 2014 Q4 | -6.08 Million USD | -8.81% |
| 2014 Q3 | -5.59 Million USD | 23.94% |
| 2014 FY | -25.59 Million USD | -3.47% |
| 2013 Q1 | -6.31 Million USD | 6.54% |
| 2013 Q2 | -6.07 Million USD | 3.92% |
| 2013 Q3 | -5.97 Million USD | 1.66% |
| 2013 Q4 | -6.37 Million USD | -6.77% |
| 2013 FY | -24.73 Million USD | -9.69% |
| 2012 Q1 | -5.48 Million USD | 30.42% |
| 2012 Q3 | -5.57 Million USD | -17.82% |
| 2012 Q4 | -6.76 Million USD | -21.32% |
| 2012 Q2 | -4.73 Million USD | 13.79% |
| 2012 FY | -22.54 Million USD | 10.72% |
| 2011 Q1 | -4.85 Million USD | -34.18% |
| 2011 Q2 | -5.38 Million USD | -10.79% |
| 2011 Q3 | -7.13 Million USD | -32.56% |
| 2011 Q4 | -7.88 Million USD | -10.55% |
| 2011 FY | -25.25 Million USD | -56.13% |
| 2010 Q3 | -4.09 Million USD | 0.5% |
| 2010 FY | -16.17 Million USD | 33.19% |
| 2010 Q1 | -4.34 Million USD | 13.29% |
| 2010 Q2 | -4.11 Million USD | 5.39% |
| 2010 Q4 | -3.61 Million USD | 11.59% |
| 2009 FY | -24.21 Million USD | 33.25% |
| 2009 Q4 | -5.01 Million USD | 30.98% |
| 2009 Q1 | -5.69 Million USD | 11.91% |
| 2009 Q2 | -6.23 Million USD | -9.43% |
| 2009 Q3 | -7.26 Million USD | -16.55% |
| 2008 Q4 | -6.46 Million USD | 35.72% |
| 2008 Q1 | -8.51 Million USD | 1.78% |
| 2008 Q2 | -11.22 Million USD | -31.83% |
| 2008 Q3 | -10.06 Million USD | 10.37% |
| 2008 FY | -36.27 Million USD | -29.42% |
| 2007 Q1 | -6.6 Million USD | -26.51% |
| 2007 Q3 | -6.45 Million USD | 2.38% |
| 2007 FY | -28.02 Million USD | -54.65% |
| 2007 Q4 | -8.66 Million USD | -34.36% |
| 2007 Q2 | -6.6 Million USD | 0.0% |
| 2006 FY | -18.12 Million USD | -62.49% |
| 2006 Q2 | -4.15 Million USD | 0.0% |
| 2006 Q4 | -5.22 Million USD | -25.74% |
| 2006 Q3 | -4.15 Million USD | 0.0% |
| 2006 Q1 | -4.15 Million USD | -48.2% |
| 2005 Q2 | -2.8 Million USD | 0.0% |
| 2005 FY | -11.15 Million USD | -223.37% |
| 2005 Q1 | -2.8 Million USD | 0.0% |
| 2005 Q4 | -2.8 Million USD | 0.0% |
| 2005 Q3 | -2.8 Million USD | 0.0% |
| 2004 FY | -3.44 Million USD | -81.42% |
| 2003 FY | -1.9 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -1.936% |
| Cerus Corporation | -30.05 Million USD | 51.289% |
| OrthoPediatrics Corp. | -25.76 Million USD | 43.185% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -37.826% |
| Talis Biomedical Corporation | -66.81 Million USD | 78.09% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 15.362% |
| Inogen, Inc. | -109.38 Million USD | 86.617% |
| Spectral AI, Inc. | -12.98 Million USD | -12.746% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 76.611% |
| CVRx, Inc. | -43.1 Million USD | 66.037% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -314.938% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -17.79% |
| Orthofix Medical Inc. | -139.11 Million USD | 89.477% |
| Venus Concept Inc. | -28.3 Million USD | 48.289% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 72.905% |
| Bioventus Inc. | -81.72 Million USD | 82.087% |
| BrainsWay Ltd. | -4.92 Million USD | -197.118% |
| Envoy Medical, Inc. | -18.37 Million USD | 20.315% |
| electroCore, Inc. | -18.8 Million USD | 22.154% |
| IceCure Medical Ltd | -15.57 Million USD | 6.016% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 69.805% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 15.225% |
| MaxCyte, Inc. | -48.29 Million USD | 69.691% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -22.448% |
| Nexalin Technology, Inc. | -5.69 Million USD | -156.992% |
| PAVmed Inc | -68.79 Million USD | 78.721% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 74.119% |
| RxSight, Inc. | -50.08 Million USD | 70.772% |
| Sight Sciences, Inc. | -57.27 Million USD | 74.44% |
| SI-BONE, Inc. | -46.93 Million USD | 68.807% |
| TELA Bio, Inc. | -44.07 Million USD | 66.786% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 72.966% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 71.535% |
| LivaNova PLC | -68.49 Million USD | 78.629% |
| 908 Devices Inc. | -42.75 Million USD | 65.763% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 91.557% |
| Nemaura Medical Inc. | -9.59 Million USD | -52.565% |
| NeuroPace, Inc. | -27.17 Million USD | 46.129% |
| LENSAR, Inc. | -12.22 Million USD | -19.707% |
| Apyx Medical Corporation | -17.25 Million USD | 15.18% |
| Cutera, Inc. | -156.23 Million USD | 90.63% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -70.142% |
| BioSig Technologies, Inc. | -28.51 Million USD | 48.657% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 83.296% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 34.781% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 113.126% |
| Axonics, Inc. | -26.05 Million USD | 43.819% |
| Outset Medical, Inc. | -169.77 Million USD | 91.377% |
| IRIDEX Corporation | -10 Million USD | -46.288% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 86.591% |
| IRadimed Corporation | 20.03 Million USD | 173.065% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -77.55% |
| INVO Bioscience, Inc. | -6.76 Million USD | -116.324% |
| Telesis Bio, Inc. | -35.15 Million USD | 58.353% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 202.156% |
| Varex Imaging Corporation | 32.1 Million USD | 145.604% |
| Quipt Home Medical Corp. | 3.91 Million USD | 473.539% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -20.654% |
| Pulmonx Corporation | -61.93 Million USD | 76.364% |
| Dynatronics Corporation | -2.27 Million USD | -544.025% |
| Modular Medical, Inc. | -17.52 Million USD | 16.487% |
| Semler Scientific, Inc. | 22.25 Million USD | 165.776% |
| InMode Ltd. | 195.66 Million USD | 107.482% |
| Bruker Corporation | 436.9 Million USD | 103.351% |
| Cytosorbents Corporation | -31.2 Million USD | 53.094% |
| DexCom, Inc. | 597.7 Million USD | 102.449% |
| Align Technology, Inc. | 643.33 Million USD | 102.275% |
| Viveve Medical, Inc. | -21.55 Million USD | 32.079% |
| ZimVie Inc. | -30.93 Million USD | 52.684% |
| Movano Inc. | -29.69 Million USD | 50.694% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 47.427% |
| Nexalin Technology, Inc. | -5.69 Million USD | -156.992% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -314.938% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 93.723% |
| Profound Medical Corp. | -28.61 Million USD | 48.843% |
| Insulet Corporation | 220 Million USD | 106.654% |
| enVVeno Medical Corporation | -25.23 Million USD | 41.996% |
| Surmodics, Inc. | -5.64 Million USD | -159.327% |
| iCAD, Inc. | -7.68 Million USD | -90.389% |
| Nuwellis, Inc. | -17.63 Million USD | 16.965% |
| Biotricity, Inc. | -8.82 Million USD | -65.82% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 88.304% |
| Aethlon Medical, Inc. | -12.63 Million USD | -15.846% |
| InspireMD, Inc. | -21.14 Million USD | 30.762% |
| PAVmed Inc. | -68.79 Million USD | 78.721% |
| BIOLASE, Inc. | -17.93 Million USD | 18.387% |
| Beyond Air, Inc. | -63 Million USD | 76.766% |
| FONAR Corporation | 16.53 Million USD | 188.531% |
| AxoGen, Inc. | -21.46 Million USD | 31.791% |
| Vivani Medical, Inc. | -26.96 Million USD | 45.711% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 181.143% |
| Inari Medical, Inc. | -14.03 Million USD | -4.326% |
| UFP Technologies, Inc. | 57.66 Million USD | 125.387% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -197.082% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -132.152% |
| Tenon Medical, Inc. | -15.72 Million USD | 6.918% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -95.866% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 65.722% |
| AdaptHealth Corp. | -598.4 Million USD | 97.554% |
| Sintx Technologies, Inc. | -13.35 Million USD | -9.59% |
| NanoVibronix, Inc. | -3.43 Million USD | -326.048% |
| Quanterix Corporation | -49.7 Million USD | 70.546% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -20.654% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -3732.199% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 95.623% |
| TransMedics Group, Inc. | -28.72 Million USD | 49.041% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 38.002% |
| NeuroMetrix, Inc. | -7.15 Million USD | -104.698% |
| Hyperfine, Inc. | -48.11 Million USD | 69.575% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 77.487% |
| Biomerica, Inc. | -6.36 Million USD | -129.92% |
| Bone Biologics Corporation | -9.42 Million USD | -55.267% |
| AVITA Medical, Inc. | -40.4 Million USD | 63.767% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -41.972% |
| Silk Road Medical, Inc | -59.27 Million USD | 75.302% |